BPG is committed to discovery and dissemination of knowledge
Citation
Kawasaki E, Nakano Y, Fukuyama T, Uchida A, Sagara Y, Tamai H, Tojikubo M, Hiromatsu Y, Koga N. Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes. World J Diabetes 2021; 12(12): 2087-2095 [PMID: 35047122 DOI: 10.4239/wjd.v12.i12.2087]
Please LOGIN to submit a new comment.